Marshall Wace »

Perspective Therapeutics shares owned by Marshall Wace

Quarter-by-quarter ownership of Perspective Therapeutics (CATX) shares owned by Marshall Wace from 13F filings

Historical chart of Marshall Wace investment in Perspective Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Perspective Therapeutics held by Marshall Wace consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Perspective Therapeutics by Marshall Wace

Quarter filed Position value Share count Share price at filing
2024-06-30 $13M 1.3M 9.97

More positions owned by Marshall Wace

Ishares-s&p 500 Etp (IVV)
Amazon.com Equity Option Put Option (AMZN)
Microsoft Corp Equity Option Put Option (MSFT)
Apple Common Stock (AAPL)
Spdr S&p 500 Etf Equity Option Call Option (SPY)
Nvidia Corp Equity Option Call Option (NVDA)
Alphabet Inc-a Common Stock (GOOGL)
Eli Lilly & Co Common Stock (LLY)
Alphabet Inc-c Common Stock (GOOG)
Adobe Common Stock (ADBE)
Meta Platforms-a Common Stock (META)
Johnson&johnson Common Stock (JNJ)
Humana Common Stock (HUM)
Boston Scientifc Common Stock (BSX)
Costco Wholesale Common Stock (COST)

View all positions for Marshall Wace

Top funds holding Perspective Therapeutics

Commodore Capital
Henderson Group
BlackRock
Avidity Partners Management
Vanguard Group
Deerfield Management Company
Nicholson Wealth Management Group
Octagon Capital Advisors
Marshall Wace
Geode Capital Management
Hills Bank And Trust Company
State Street Corporation
Ghost Tree Capital
Paradigm Biocapital Advisors
Sphera Funds Management

View all funds holding Perspective Therapeutics